Girihlet

Girihlet is a private U.S. biotech and diagnostics company focused on immune profiling for autoimmune disease. The company is developing and offering ImmuneScanner, a platform that combines proprietary assays, T-cell receptor sequencing, and computational algorithms to monitor responses to autoimmune therapies and support treatment selection. Girihlet also describes Tseek as the data-generation component of its platform for profiling T cells in humans and animals. Its work is centered on turning immune repertoire data into actionable biomarkers, with a noted collaboration with Mayo Clinic in ankylosing spondylitis. The company appears to be an early-stage, platform-oriented health technology business rather than a traditional therapeutics developer.